Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · Real-Time Price · USD
1.770
-0.030 (-1.67%)
At close: Dec 20, 2024, 4:00 PM
1.710
-0.060 (-3.39%)
After-hours: Dec 20, 2024, 5:38 PM EST

Avenue Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Net Income
-9.47-10.38-3.55-3.73-5.15-25.91
Upgrade
Asset Writedown & Restructuring Costs
-3----
Upgrade
Stock-Based Compensation
1.020.910.650.440.711.84
Upgrade
Other Operating Activities
-1.6-2.69-5.1---
Upgrade
Change in Accounts Receivable
0.01-0.09-0.09--
Upgrade
Change in Accounts Payable
-0.78-0.360.35-0.38-0.23-3.23
Upgrade
Change in Other Net Operating Assets
0.230.07-0.030.010.061.04
Upgrade
Operating Cash Flow
-10.59-9.45-7.6-3.75-4.61-26.26
Upgrade
Sale (Purchase) of Intangibles
--3----
Upgrade
Other Investing Activities
-----1-
Upgrade
Investing Cash Flow
--3---1-
Upgrade
Issuance of Common Stock
14.167.5311.655.04-35
Upgrade
Repurchase of Common Stock
---1.1---
Upgrade
Other Financing Activities
-1.14---0.66--2.67
Upgrade
Financing Cash Flow
13.027.5310.544.38-32.33
Upgrade
Net Cash Flow
2.44-4.932.950.63-5.616.07
Upgrade
Free Cash Flow
-10.59-9.45-7.6-3.75-4.61-26.26
Upgrade
Free Cash Flow Per Share
-11.88-66.92-260.72-248.20-314.41-1879.00
Upgrade
Levered Free Cash Flow
-10.1-13.49-1.25-2.36-3.72-15.93
Upgrade
Unlevered Free Cash Flow
-10.1-13.49-1.25-2.36-3.72-15.93
Upgrade
Change in Net Working Capital
3.742.31-3.130.461.171.36
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.